These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

241 related articles for article (PubMed ID: 53279)

  • 1. Technetium-99m labeling by means of stannous pyrophosphate: application to bleomycin and red blood cells.
    Bardy A; Douyé H; Gobin R; Beydon J; de Tovar G; Pannecière C; Hégésippe M
    J Nucl Med; 1975 May; 16(5):435-7. PubMed ID: 53279
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vitro technetium-99m red blood cell labeling using commercial stannous pyrophosphate.
    Zimmer AM
    Am J Hosp Pharm; 1977 Mar; 34(3):264-7. PubMed ID: 857670
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficiency of in vivo labeling of red blood cells with 99mTc.
    Colombetti LG; Siddiqui A
    Nuklearmedizin; 1976 Oct; 15(5):211-3. PubMed ID: 1005126
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Technetium-99m labeling of red blood cells: in vitro evaluation of a new approach.
    Kelbaek H
    J Nucl Med; 1986 Nov; 27(11):1770-3. PubMed ID: 3772511
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of labeling procedures and in vivo stability of 99mTc-red blood cells.
    Ryo UY; Mohammadzadeh AA; Siddiqui A; Colombetti LG; Pinsky SM
    J Nucl Med; 1976 Feb; 17(02):133-6. PubMed ID: 1245875
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vivo labeling of red blood cells with Tc-99m with stannous pyridoxylideneaminates.
    Kato M
    J Nucl Med; 1979 Oct; 20(10):1071-4. PubMed ID: 536758
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Stoichiometric Tc-99m RBC labeling using stable kit solutions of stannous chloride and EDTA: concise communication.
    Mock BH; Wellman HN
    J Nucl Med; 1984 Aug; 25(8):881-6. PubMed ID: 6431061
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A comparative evaluation of techniques for rapid and efficient in vivo labeling of red cells with [99mTc] pertechnetate.
    Hamilton RG; Alderson PO
    J Nucl Med; 1977 Oct; 18(10):1010-3. PubMed ID: 903468
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of Sn(II) ion concentration and heparin on technetium-99m red blood cell labeling.
    Rao SA; Knobel J; Collier BD; Isitman AT
    J Nucl Med; 1986 Jul; 27(7):1202-6. PubMed ID: 3014088
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Leukocyte labeling with technetium-99m tin colloids.
    Mock BH; English D
    J Nucl Med; 1987 Sep; 28(9):1471-7. PubMed ID: 3625299
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vivo labeling of red blood cells with 99mTc: a new approach to blood pool visualization.
    Pavel DG; Zimmer M; Patterson VN
    J Nucl Med; 1977 Mar; 18(3):305-8. PubMed ID: 839281
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of formamidine sulfinic acid and other reducing agents for use in the preparation of Tc-99m labeled radiopharmaceuticals.
    Fritzberg AR; Lyster DM; Dolphin DH
    J Nucl Med; 1977 Jun; 18(6):553-7. PubMed ID: 192859
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Technical parameters of in vivo red blood cell labeling with Technetium-99m.
    Zimmer AM; Pavel DG; Karesh SM
    Nuklearmedizin; 1979 Dec; 18(5):241-5. PubMed ID: 547251
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Technetium-99m radiopharmaceutical preparation by surface adsorbed stannous ions.
    Salehi N; Lichtenstein M; Pojer PM
    J Nucl Med; 1987 Jun; 28(6):1041-6. PubMed ID: 3675734
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mechanistic aspects of the interaction of 99mTc in association with stannous pyrophosphate with damaged red blood cells.
    Billinghurst MW; Waddell TL
    Int J Appl Radiat Isot; 1983 Mar; 34(3):607-12. PubMed ID: 6303965
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Labeling of red blood cells with Tc-99m after oral administration of SnCl2: concise communication.
    Patel MC; Parab PB; Samuel AM; Ganatra RD
    J Nucl Med; 1979 Aug; 20(8):877-81. PubMed ID: 541736
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A new stannous agent kit for labelling red blood cells with 99TCM and its clinical application.
    Ducassou D; Arnaud D; Bardy A; Beydon J; Baquey C
    Br J Radiol; 1976 Apr; 49(580):344-7. PubMed ID: 181112
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Influence of tobacco on the labelling of red blood cells and plasma proteins with technetium-99m.
    Vidal MV; Gutfilen B; da Fonseca LM; Bernardo-Filho M
    J Exp Clin Cancer Res; 1998 Mar; 17(1):41-6. PubMed ID: 9646232
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Technetium-99m labeling of polymorphonuclear leukocytes: preparation with two different stannous agents.
    Kelbaek H; Fogh J
    J Nucl Med; 1985 Jan; 26(1):68-71. PubMed ID: 3965654
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Technical problems associated with the production of technetium Tc 99m tin(II) pyrophosphate kits.
    Kowalsky RJ; Dalton DR
    Am J Hosp Pharm; 1981 Nov; 38(11):1722-6. PubMed ID: 7304626
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.